Saint Louis University

To build better TB vaccines, Saint Louis University researchers develop a new model by leveraging an old vaccine

Each year, tuberculosis (TB) kills more people than any other infectious disease, falling out of the top spot only temporarily during the COVID-19 pandemic.

Read More →

With a focus on high-risk patients, SLU researcher eyes eliminating TB for good

In a recent paper published in PLOS One, Soumya Chatterjee, M.D., assistant professor of infectious diseases, allergy and immunology at Saint Louis University, presents data to show that a focus on high-risk tuberculosis patients may be the answer to stalled progress in stamping out the illness in the United States. 

Read More →

NIH funds SLU research of possible treatment for drug-resistant TB

Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

Read More →

Page 1 of 1 · Total posts: 3